🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to evaluate whether bemnifosbuvir (BEM) is effe...
Status
Completed
Location
Atea Study Site
Start Date
2022-11-25
Trial ID
NCT05629962
Treatments Being Tested
The objectives of this study are to evaluate the safety, tolerability, anti...
Status
Terminated
Location
Atea Study Site
Start Date
2020-05-26
Trial ID
NCT04396106
To Assess the Effect of Hepatic Impairment on the Pharmacokinetics of Bemni...
Status
Completed
Location
Atea Study Site Orlando Clinical Research Center
Start Date
2023-01-30
Trial ID
NCT05724693
Treatments Being Tested
Drug-drug interaction study of midazolam and AT-527 (R07496998)...
Status
Completed
Location
Atea Study Site
Start Date
2021-04-22
Trial ID
NCT04865445
Treatments Being Tested
This study will assess the safety, tolerability and bronchopulmonary pharma...
Status
Completed
Location
Atea Study Site
Start Date
2021-04-25
Trial ID
NCT04877769
Treatments Being Tested
To Assess the Effect of Severe Hepatic or Renal Impairment on the Pharmacok...
Status
Completed
Location
Atea Study Site
Start Date
2025-04-09
Trial ID
NCT06911320
Treatments Being Tested
This study will evaluate the efficacy, safety, antiviral activity, and phar...
Status
Terminated
Location
Instituto Ave Pulmo
Start Date
2021-04-28
Trial ID
NCT04889040
Drug-drug interaction study of Ruzasvir and Bemnifosbuvir...
Status
Completed
Location
Atea Study Site
Start Date
2023-01-30
Trial ID
NCT05731843
Treatments Being Tested
This study will assess the safety, tolerability and pharmacokinetics (PK) o...
Status
Completed
Location
Atea Study Site
Start Date
2023-04-26
Trial ID
NCT05905497
Treatments Being Tested
This study will assess the safety, tolerability and pharmacokinetics (PK) o...
Status
Completed
Location
Atea Study Site
Start Date
2020-11-02
Trial ID
NCT04711187
Treatments Being Tested